Advertisement

Persons > All
Find below all kinds of persons.Total search results: 8687 | Ordered by Person (ascending)
1 2 3 ... 85 86 87
![]() ![]() |
![]() ![]() |
![]() ![]() |
![]() ![]() |
---|---|---|---|
à Brassard, Lothar (Chemagen 201102 CEO) | Chief Executive Officer (CEO) | PerkinElmer (Group) | Germany |
Aabo, Gitte (Leo Pharma 201511 CEO) | Chief Executive Officer (CEO) | Leo Pharma (Group) | Denmark |
Aamund, Asger (Bavarian Nordic 200804 Chairman) | n. a. | Bavarian Nordic (Group) | Denmark |
Aasen, Thomas H. (Acadia 200409) | n. a. | Acadia (Group) | United States (USA) |
Abastado, Jean-Pierre (Servier 201507 Director Oncology Innovation Therapeutic Pole) | Research & Development Manager | Servier (Group) | France |
Abbey, Jeff (Argos Therapeutics 200604 VP Business Development) | Business Development Manager / Strategy Manager | Argos Therapeutics (Group) | United States (USA) |
Abdun-Nabi, Daniel (Emergent BioSolutions 200806 President + COO) | Chief Operating Officer (COO) | Emergent BioSolutions (Group) | United States (USA) |
Abel, Stan E. (Corthera 200712– CEO before Cerexa Inc CFO + co-founder before Peninsula Pharma CFO before Lilly) | Chief Executive Officer (CEO) | Novartis (Group) | United States (USA) |
Abercrombie, George (Roche US 200609 President + CEO) | Chief Executive Officer (CEO) | Roche (Group) | United States (USA) |
Aberman, Zami (Pluristem 201404 CEO) | Chief Executive Officer (CEO) | Pluristem (Group) | Israel |
Abi-Saab, Walid (Galapagos 201809 CMO) | Chief Medical Officer (CMO) | Galapagos (Group) | Belgium |
Abitorabi, Abi (Girus Life Sciences 200710 CEO) | Chief Executive Officer (CEO) | Girus Life Sciences Inc. | United States (USA) |
Abken, Hinrich (Univ Cologne 201507 Prof at CMMC) | Professor | University of Cologne (Universität zu Köln) | Germany |
Abraham, Robert (Pfizer 201412 SVP + CSO at Onology Research Unit) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Pfizer (Group) | United States (USA) |
Abribat, Thierry (Alizé Pharma 2007– President + Founder) | Chief Executive Officer (CEO) | Alizé Pharma (Group) | France |
Acciarito, Tony (Thermo Fisher 201609 VP + General Manager Thermo Fisher South Korea) | General Manager (management) | Thermo Fisher (Group) | Korea, Republic of |
Ackerman, Samuel K. (Panacos 200508 CEO) | Chief Executive Officer (CEO) | Panacos Pharmaceuticals Inc. (Nasdaq: PANC) | United States (USA) |
Ackermann, Niels (BioXell 200704– CFO before Morgan Stanley London + CFO of two German biotech companies) | Chief Financial Officer (CFO) | Cosmo Pharmaceuticals (Group) | Italy |
Adachi, Tamotsu (Carlyle Group Japan 200508) | n. a. | Carlyle Group, The | United States (USA) |
Adachi, Yoroku (Canon USA 200504– President + CEO) | Chief Executive Officer (CEO) | Canon (Group) | United States (USA) |
Adair, Fiona (Haptogen 200507– before Biovation + CXR Biosciences) | n. a. | Pfizer (Group) | United Kingdom (GB) |
Adam, George F. (Rick) (Recondo Technology –200711–200811– Member of the Board of Directors) | Board member | Recondo Technology Inc. | United States (USA) |
Adamis, Anthony P. (Jerini Ophthalmic 200703– CEO) | Chief Executive Officer (CEO) | Shire (Group) | United States (USA) |
Adams, Adrian (Auxilium 201112– CEO before Neurologix + Inspire Pharma + Sepracor + Kos + Novartis UK) | Chief Executive Officer (CEO) | Dainippon Sumitomo (Group) | United States (USA) |
Adams, Christoph M. (FoldRx 200509– CBO before ViaCell Senior VP BusDev) | Chief Business Officer (CBO) | FoldRx Pharmaceuticals Inc. | United States (USA) |
Adams, George (Amorfix 200601 CEO) | Chief Executive Officer (CEO) | Amorfix Life Sciences Ltd. (TSX-V: AMF) | Canada |
Adams, Jan (EMBL 201411 Managing Director at EMBL Ventures joined 2002) | Managing Director | EMBL (European Molecular Biology Laboratory) | Germany |
Adams, Terry (Shimadzu 201406 VP Marketing at SSI) | Sales Manager / Marketing Manager | Shimadzu (Group) | United States (USA) |
Adams, Timothy M. (Tim) (ObsEva 201701– CFO located in US before Demandware + athenahealth + Cytyc) | Chief Financial Officer (CFO) | ObsEva (Group) | Switzerland |
Adams, Tom (Monsanto 201708 VP Biotechnology) | President/Director/Head Business Group/Unit/Division | Monsanto (Group) | United States (USA) |
Adelhelm, Karin (Clondiag 200502) | n. a. | Alere (Group) | Germany |
Adelman, Burt (Dyax 2012–2016 EVP + CMO before Eleven Biotherapeutics + Biogen) | Board member, non-executive | Shire (Group) | United States (USA) |
Adelman, Robert (venBio 201204 Partner before OrbiMed Advisors + founder of Operon Technologies + Roka Bioscience) | Partner (venture partner) | VenBio Partners | United States (USA) |
Adelus, Benoît (Sebia 200802– before Eurofins EVP + bioMérieux CEO + Merial) | Chief Executive Officer (CEO) | Sebia (Group) | France |
Adewoye, Henry (Compugen 201803– CMO before Gilead Sciences + Amgen) | Chief Medical Officer (CMO) | Compugen (Group) | Israel |
Adkin, Gregg (Dell 201705 VP + Managing Director of Dell Technologies Capital) | Managing Director | Dell (Group) | |
Adkins, John (Sterilin 200806 CEO) | Chief Executive Officer (CEO) | Thermo Fisher (Group) | United Kingdom (GB) |
Aebersold, Ruedi (ETH Zurich 2005c– Professor Systems Biology before Institute of Systems Biology Seattle) | Professor | ETH Zürich (ETHZ) | Switzerland |
Afeyan, Noubar (Flagship Ventures 200603 managing partner + CEO) | Chief Executive Officer (CEO) | Flagship Pioneering | United States (USA) |
Afflerbach, Henning (Coral BioNet 201205 CBO at Scil Proteins) | Chief Business Officer (CBO) | UV-Cap (Group) | Germany |
Afonso, Carlos (Univ Rouen 201606) | Laboratory Manager (industry) | University of Rouen (Université de Rouen) | France |
Afshar, Mohammad (Ariana Pharmaceuticals 2002– CEO + Founder) | Chief Executive Officer (CEO) | Ariana Pharmaceuticals (Group) | France |
Aggarwal, Vijay (Aureon Laboratories 200410– before SKB + Quest Diagnostics) | n. a. | Aureon Laboratories Inc. | United States (USA) |
Agger, Mette Kirstine (Lundbeck 201411 Managing Partner at Lundbeckfonden Ventures before 7TM Pharma CEO) | Managing Partner (investment firm) | Lundbeck (Group) | Denmark |
Aghazadeh, Behzad (venBio 2011– Partner before Sio Capital Management + AllianceBernstein + Booz Allen) | Partner (venture partner) | VenBio Partners | United States (USA) |
Agrawal, Nitin (Texas A&M Univ 200705 Chemical Engineering) | n. a. | Texas A&M University System (TAMU) | United States (USA) |
Agrawal, Sudhir (Hybridon 200506 CEO + CSO) | Chief Executive Officer (CEO) | Idera Pharmaceuticals Inc. (Nasdaq: IDRA) | United States (USA) |
Agrawal, Sudhir (Idera 200612 CEO + CSO) | Chief Executive Officer (CEO) | Idera Pharmaceuticals Inc. (Nasdaq: IDRA) | United States (USA) |
Aguiar, Michael (Theravance 200601 Senior VP + CFO) | Chief Financial Officer (CFO) | Innoviva (Group) | United States (USA) |
Aguiar-Lucander, Renée (Pharmalink AB 201708 CEO) | Chief Executive Officer (CEO) | Calliditas Therapeutics AB | Sweden |
Ahanola, Jani (Noona Healthcare 201611 CEO) | Chief Executive Officer (CEO) | Noona Healthcare (FI) | Finland |
Ahlberg, Christopher (Spotfire 200505 CEO) | Chief Executive Officer (CEO) | TIBCO Software (Group) | United States (USA) |
Ahmad, Shidah (Agilent 201204 VP + General Manager) | General Manager (management) | Agilent (Group) | United States (USA) |
Ahmadi, Khatereh (Merck (US) 201810 Executive Director Business Development + Licensing) | Business Development Manager / Strategy Manager | Merck (US) (MSD) (Group) | United States (USA) |
Ahrens, Brent (Canaan Partners 201603 General Partner) | General Partner (venture partner) | Canaan Partners (Group) | United States (USA) |
Ahuja, Parmeet (Agilent 201103 Country General Manager India) | Regional manager | Agilent Technologies Inc. (NYSE: A) | India |
Aiach, Karen (Lysogene 201206 CEO + Founder) | Chief Executive Officer (CEO) | Lysogene S.A. (Euronext Paris: LYS) | France |
Akhlagi, Fatemah (Univ Rhode Island 201007 Assoc Prof Pharmacokinetics at School of Pharmacy) | Assistant Professor / Associate Professor | University of Rhode Island | United States (USA) |
Akin, Tom (CombiMatrix 201004 Board Chairman) | Board member, non-executive | CombiMatrix (Group) | United States (USA) |
Akiyama, Al (Beckman 200606) | n. a. | Danaher (Group) | United States (USA) |
Akkaraju, Srinivas (Samsara BioCaptial 2016– Founder) | Investment Manager | Samsara BioCapital | |
Al-Hashimi, Hashim M. (Univ Michigan 201304 Professor of Chemistry + Biophysics) | Professor | University of Michigan | United States (USA) |
Alag, Satnam (NextBio 201310 CTO) | Chief Technology/Technical Officer (CTO) | Illumina (Group) | United States (USA) |
Alaix, Juan Ramón (Pfizer 201005 President Pfizer Animal Health) | President/Director/Head Business Group/Unit/Division | Pfizer (Group) | United States (USA) |
Alba, Florent (NewCap 201502) | Public Relations Manager / Investor Relations Manager | NewCap. – Investor Relations & Financial Communications | France |
Alberici, Gilles (Orega Biotech 201601 CEO before Octalfa 2009 President before OPi SA founder + president) | Chief Executive Officer (CEO) | Orega Biotech (FR) | France |
Albers, Jeffrey W. (Jeff) (Blueprint Medicinces 201201– President of Algeta US + Genzyme + Mintz Levin) | Chief Executive Officer (CEO) | Blueprint Medicines Corporation (Nasdaq: BPMC) | United States (USA) |
Albert, Keith (ARTEL 200801 Technical Marketing Manager) | Sales Manager / Marketing Manager | Artel (USA) | United States (USA) |
Albert, Matthew (Institut Pasteur 201501 Director of Immunology Dept) | President/Director/Head of Research Organisation/Unit | Institut Pasteur | France |
Albert, Thomas (NimbleGen Systems 200707 Director Advanced Research) | n. a. | Roche (Group) | United States (USA) |
Albini, Edward C. (Novacea 200402– CFO before Lynx Therapeutics before Genentech) | Chief Financial Officer (CFO) | Transcept Pharmaceuticals (Group) | United States (USA) |
Albrecht, Claudio (Actavis 201201 CEO) | Chief Executive Officer (CEO) | Teva (Group) | Iceland |
Albrecht, Uwe (Mediconomics 201704 Managing Director) | Managing Director | Mediconomics GmbH | Germany |
Aldag, Jörn (Hookipa Biotech 201606– CEO before Uniqure/AMT + Evotec + MAN GHH) | Chief Executive Officer (CEO) | Hookipa (Group) | Austria |
Alden, Gerry (Velocity11 –200601– General Manager Europe) | General Manager (management) | Agilent (Group) | United States (USA) |
Alden, Morgen (LifeSci Advisors 201711 KOL Strategy + Management) | n. a. | LifeSci (Group) | United States (USA) |
Alder, Matthias (Autolus 201707– CBO + General Counserl before Sucampp + Cytos Biotechnology + Micromet + Cooley LLP) | Chief Business Officer (CBO) | Autolus Therapeutics plc (Nasdaq: AUTL) | United Kingdom (GB) |
Aldrich, Richard (Rich) (Longwood Fund 201810 General Partner + Co-founder + RA Capital before Altus + Vertex) | General Partner (venture partner) | Longwood Fund | United States (USA) |
Aleotti, Alberto Giovanni (Menarini 201210 Board Member of A. Menarini) | Board member | Menarini (Group) | Italy |
Aleotti, Lucia (Menarini 201611 Group Chairman) | Chief Executive Officer (CEO) | Menarini (Group) | Italy |
Alexander, David (Adecco 201709 President North America Financa, Office + Healthcare businesses) | President/Director/Head Business Group/Unit/Division | Adecco (Group) | Switzerland |
Alexander, Robert (ZS Pharma 201511 CEO) | Chief Executive Officer (CEO) | AstraZeneca (Group) | United States (USA) |
Alexander, Susan H. (Biogen Idec 200601– before Parexel) | n. a. | Biogen (Group) | United States (USA) |
Alexandrov, Alexander (MYR GmbH 201203 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | MYR GmbH | Germany |
Alexandrov, Theodore (EMBL 201410– Team Leader at EMBL Heidelberg before Univ Bremen) | Researcher (university / research institute) | EMBL (European Molecular Biology Laboratory) | Germany |
Alexandrova, Natalia (Ariadne Genomics 200605) | n. a. | Reed Elsevier (Group) | United States (USA) |
Alexandru, Anca (Affimed 201602– Head of Communications before MacDougall 201501 European Office) | Public Relations Manager / Investor Relations Manager | Affimed (Group) | Germany |
Alexanyan, Vladimir (Valtex 1982– Founder) | Company Founder | Valtex (Group) | United States (USA) |
Ali, Muraf (Generex Biotechnology 200506 VP Clinical + Regulatory Affairs before Ingenix) | Chief Medical Officer (CMO) | Generex Biotechnology (Group) | Canada |
Ali, Shahid (Neopharm 200709– Executive VP RnD) | Research & Development Manager | NeoPharm Inc. | United States (USA) |
Alivisatos, Paul | n. a. | United States (govt) | United States (USA) |
Allaer, Didier (Diagenode 201105 CEO) | Chief Executive Officer (CEO) | Diagenode (Group) | Belgium |
Allan, Eva-Lotta (Immunocore 201305– CBO before Ablynx 200606– CBO before Vertex Pharmaceuticals) | Chief Business Officer (CBO) | Immunocore (Group) | United Kingdom (GB) |
Allan, Geoffrey (Insmed –200712– CEO) | Chief Executive Officer (CEO) | Insmed (Group) | United States (USA) |
Alland, Leila (Affimed 201803– CMO before Tarveda Therapeutics + AstraZeneca + BMS + Novartis) | Chief Medical Officer (CMO) | Affimed (Group) | Germany |
Allaway, Graham P. (Panacos 200605 COO) | n. a. | Panacos Pharmaceuticals Inc. (Nasdaq: PANC) | United States (USA) |
Allemond, Pierre (Protein Metrics 201510– VP European Sales before Biovia/Dassault Systèmes + Accelrys + Chemspeed) | Sales Manager / Marketing Manager | Protein Metrics Inc. | Switzerland |
Allen, Andrew (Gritstone Oncology 201808 CEO) | Chief Executive Officer (CEO) | Gritstone Oncology Inc. | United States (USA) |
Allen, Chris (Broughton Laboratories 2011– Managing Director joind as Co-Founder 2006 before Sciantec Analytical) | Managing Director | Broughton Laboratories (GB) | United Kingdom (GB) |
Allen, Dave (GSK 201609 SVP KSG Pharma RnD) | n. a. | GlaxoSmithKline (GSK) (Group) | United Kingdom (GB) |


Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top